Works matching DE "IRINOTECAN"

Results: 1726

The War on Pancreatic Cancer: We Are Not There Yet.

Published in:

2014

By:

VARADHACHARY, GAURI R.;
WOLFF, ROBERT A.

Publication type:

Opinion

Treatment of Metastatic Pancreatic Adenocarcinoma: New Options and Promising Strategies.

Published in:

2014

By:

LOWERY, MAEVE A.;
O'REILLY, EILEEN M.

Publication type:

Opinion

Treatment of Metastatic Pancreatic Adenocarcinoma: A Review.

Published in:

Oncology (08909091), 2014, v. 28, n. 1, p. 70

By:

THOTA, RAMYA;
BERLIN, JORDAN D.;
PAUFF, JAMES M.

Publication type:

Article

Expanding Options for Pancreatic Cancer... So Where Do We Go From Here?

Published in:

Oncology (08909091), 2014, v. 28, n. 1, p. 5

By:

KO, ANDREW H.

Publication type:

Article

Self‐Thermophoretic Nanoparticles Enhance Intestinal Mucus Penetration and Reduce Pathogenic Bacteria Interception in Colorectal Cancer.

Published in:

Advanced Functional Materials, 2023, v. 33, n. 17, p. 1, doi. 10.1002/adfm.202212013

By:

Wang, Zhi‐Hao;
Huang, Wanting;
Zhang, Shuhao;
Chu, Mengyu;
Yin, Na;
Zhu, Chaoran;
Zhang, Zhenzhong;
Shi, Jinjin;
Liu, Junjie

Publication type:

Article

Nanodrug Carrier Based on Poly(Ursolic Acid) with Self‐Anticancer Activity against Colorectal Cancer.

Published in:

Advanced Functional Materials, 2020, v. 30, n. 9, p. 1, doi. 10.1002/adfm.201907857

By:

Ou, Kunyong;
Xu, Xiaojun;
Guan, Shuyu;
Zhang, Ruhe;
Zhang, Xinyu;
Kang, Yang;
Wu, Jun

Publication type:

Article

Biodegradable Fluorescent Nanoparticles for Endoscopic Detection of Colorectal Carcinogenesis.

Published in:

Advanced Functional Materials, 2019, v. 29, n. 51, p. N.PAG, doi. 10.1002/adfm.201904992

By:

Rogalla, Stephan;
Flisikowski, Krzysztof;
Gorpas, Dimitris;
Mayer, Aaron T.;
Flisikowska, Tatiana;
Mandella, Michael J.;
Ma, Xiaopeng;
Casey, Kerriann M.;
Felt, Stephen A.;
Saur, Dieter;
Ntziachristos, Vasilis;
Schnieke, Angelika;
Contag, Christopher H.;
Gambhir, Sanjiv S.;
Harmsen, Stefan

Publication type:

Article

Covalent Organic Framework‐Supported Molecularly Dispersed Near‐Infrared Dyes Boost Immunogenic Phototherapy against Tumors.

Published in:

Advanced Functional Materials, 2019, v. 29, n. 46, p. N.PAG, doi. 10.1002/adfm.201902757

By:

Gan, Shaoju;
Tong, Xiaoning;
Zhang, Yue;
Wu, Jinhui;
Hu, Yiqiao;
Yuan, Ahu

Publication type:

Article

Zirconyl Hydrogenphosphate Nanocontainers for Flexible Transport and Release of Lipophilic Cytostatics, Insecticides, and Antibiotics.

Published in:

Advanced Functional Materials, 2019, v. 29, n. 28, p. N.PAG, doi. 10.1002/adfm.201900543

By:

Rein, Viktor;
Meschkov, Anna;
Hagens, Kristine;
Redinger, Natalja;
Schepers, Ute;
Mehlhorn, Heinz;
Schaible, Ulrich E.;
Feldmann, Claus

Publication type:

Article

Poly(Ferulic Acid) with an Anticancer Effect as a Drug Nanocarrier for Enhanced Colon Cancer Therapy.

Published in:

Advanced Functional Materials, 2019, v. 29, n. 15, p. N.PAG, doi. 10.1002/adfm.201808646

By:

Zheng, Yinghao;
You, Xinru;
Guan, Shuyu;
Huang, Jun;
Wang, Liying;
Zhang, Jiayuan;
Wu, Jun

Publication type:

Article

Evaluating the impact of loperamide on irinotecan-induced adverse events: a disproportionality analysis of data from the World Health Organization pharmacovigilance database (VigiBase).

Published in:

European Journal of Clinical Pharmacology, 2025, v. 81, n. 1, p. 129, doi. 10.1007/s00228-024-03767-6

By:

Akagi, Tomoaki;
Hamano, Hirofumi;
Miyamoto, Hirotaka;
Takeda, Tatsuaki;
Zamami, Yoshito;
Ohyama, Kaname

Publication type:

Article

Chemotherapy-induced neutropenia as a prognostic factor in patients with extensive-stage small cell lung cancer.

Published in:

European Journal of Clinical Pharmacology, 2023, v. 79, n. 3, p. 407, doi. 10.1007/s00228-023-03451-1

By:

Miyagi, Takehiro;
Tsuji, Daiki;
Kawasakai, Yohei;
Ishikawa, Hiroshi;
Tanaka, Rei;
Nakao, Masahiko;
Nakagaki, Shigeru;
Hayashi, Toshinobu;
Ayuhara, Hideaki;
Harada, Tomohiko;
Tamaki, Shinya;
Maeda, Akimitsu;
Ohashi, Yasukata;
Arakawa, Yuichiro;
Fujita, Yukiyoshi;
Yamamoto, Keisuke;
Miyamoto, Yasunori;
Yano, Takuya;
Itoh, Kunihiko

Publication type:

Article

Evaluation of pharmacogenomics and hepatic nuclear imaging–related covariates by population pharmacokinetic models of irinotecan and its metabolites.

Published in:

European Journal of Clinical Pharmacology, 2022, v. 78, n. 1, p. 53, doi. 10.1007/s00228-021-03206-w

By:

Liu, Zheng;
Martin, Jennifer H.;
Liauw, Winston;
McLachlan, Sue-Anne;
Link, Emma;
Matera, Anetta;
Thompson, Michael;
Jefford, Michael;
Hicks, Rod J.;
Cullinane, Carleen;
Hatzimihalis, Athena;
Campbell, Ian;
Crowley, Simone;
Beale, Phillip J.;
Karapetis, Christos S.;
Price, Timothy;
Burge, Mathew E.;
Michael, Michael

Publication type:

Article

Population pharmacokinetic model of irinotecan and its metabolites in patients with metastatic colorectal cancer.

Published in:

European Journal of Clinical Pharmacology, 2019, v. 75, n. 4, p. 529, doi. 10.1007/s00228-018-02609-6

By:

Oyaga-Iriarte, Esther;
Insausti, Asier;
Sayar, Onintza;
Aldaz, Azucena

Publication type:

Article

A phase I study of irinotecan and temozolomide with bevacizumab in children with recurrent/refractory central nervous system tumors.

Published in:

Child's Nervous System, 2022, v. 38, n. 5, p. 919, doi. 10.1007/s00381-022-05479-7

By:

Metts, Jonathan;
Harrington, Brittany;
Salman, Emad;
Bradfield, Scott M.;
Flanary, Jennifer;
Mosha, Maua;
Amankwah, Ernest;
Stapleton, Stacie

Publication type:

Article

Retrospective comparative study of irinotecan and pegylated liposomal doxorubicin for platinum-resistant or -refractory epithelial ovarian and primary peritoneal carcinoma.

Published in:

Archives of Gynecology & Obstetrics, 2014, v. 290, n. 5, p. 979, doi. 10.1007/s00404-014-3268-7

By:

Ichikawa, Ryoko;
Torii, Yutaka;
Oe, Shuko;
Kawamura, Kyoko;
Kato, Rina;
Hasegawa, Kiyoshi;
Udagawa, Yasuhiro

Publication type:

Article

Antiliver and Colorectal Cancer Activity Metabolites of the Fruits of Cinnamomum macrostemon.

Published in:

Chemistry of Natural Compounds, 2024, v. 60, n. 2, p. 324, doi. 10.1007/s10600-024-04313-7

By:

Chen, C. Y.;
Li, W. J.;
Li, H. T.;
Liu, S. L.;
Chuang, C. H.

Publication type:

Article

Anticolorectal Cancer Activity Metabolites from Michelia compressa.

Published in:

Chemistry of Natural Compounds, 2023, v. 59, n. 3, p. 532, doi. 10.1007/s10600-023-04043-2

By:

Chen, C. Y.;
Wang, C. H.;
Yeh, H. C.;
Huang, S. T.;
Li, W. J.;
Li, H. T.;
Chuang, C. H.

Publication type:

Article

Mechanisms of Secondary Leukemia Development Caused by Treatment with DNA Topoisomerase Inhibitors.

Published in:

Biochemistry (00062979), 2023, v. 88, n. 7, p. 892, doi. 10.1134/S0006297923070040

By:

Lomov, Nikolai A.;
Viushkov, Vladimir S.;
Rubtsov, Mikhail A.

Publication type:

Article

Antitumor effects with apoptotic death in human promyelocytic leukemia HL-60 cells and suppression of leukemia xenograft tumor growth by irinotecan HCl.

Published in:

Environmental Toxicology, 2015, v. 30, n. 7, p. 803, doi. 10.1002/tox.21959

By:

Chen, Yung‐Liang;
Chueh, Fu‐Shin;
Yang, Jai‐Sing;
Hsueh, Shu‐Ching;
Lu, Chi‐Cheng;
Chiang, Jo‐Hua;
Lee, Ching‐Sung;
Lu, Hsu‐Feng;
Chung, Jing‐Gung

Publication type:

Article

Surface enhanced Raman spectroscopy as a novel tool for rapid quantification of heroin and metabolites in saliva.

Published in:

Turkish Journal of Medical Sciences, 2020, v. 50, n. 5, p. 1470, doi. 10.3906/sag-1912-196

By:

AKÇAN, Ramazan;
YILDIRIM, Mahmut Şerif;
İLHAN, Hasan;
GÜVEN, Burcu;
TAMER, Uğur;
SAĞLAM, Necdet

Publication type:

Article

Liposomal Irinotecan Shows a Larger Therapeutic Index than Non-liposomal Irinotecan in Patient-Derived Xenograft Models of Pancreatic Cancer.

Published in:

Oncology & Therapy, 2023, v. 11, n. 1, p. 111, doi. 10.1007/s40487-022-00215-2

By:

Barbier, Sandrine;
Beaufils, Benjamin;
de Miguel, Ricardo;
Reyre, Melissa;
Le Meitour, Yannick;
Lortie, Andreanne;
de Boisferon, Marc Hillairet;
Chaumeron, Sophie;
Espirito, Anne;
Fossati, Lina;
Lagarde, Pauline;
Klinz, Stephan;
Thiagalingam, Arunthathi;
Lezmi, Stéphane;
Meyer-Losic, Florence

Publication type:

Article

INVESTIGATION OF PROTECTIVE EFFECTS OF FULLERENOL in vivo IN CHRONIC NEPHROPATHY DURING DOXORUBICIN THERAPY OF MALIGN NEOPLASM IN RATS.

Published in:

Oxidation Communications, 2024, v. 47, n. 1, p. 10

By:

INJAC, R.;
PERSE, M.;
STRUKELJ, B.;
DJORDJEVIC, A.

Publication type:

Article

The preventive effects of diosmin alone or combined with irinotecan on 1,2-dimethylhydrazine-induced colon cancer in rats.

Published in:

European Review for Medical & Pharmacological Sciences, 2024, v. 28, n. 14, p. 4003

By:

MOHAMED, K.;
ABUELSAAD, A.;
ABDELAZIZ, M.;
SAKR, H.;
ABDEL-AZIZ, A.;
AHMED, O.

Publication type:

Article

Targeting the monocarboxylate transporter MCT2 and lactate dehydrogenase A LDHA in cancer cells with FX-11 and AR-C155858 inhibitors.

Published in:

European Review for Medical & Pharmacological Sciences, 2023, v. 27, n. 14, p. 6605

By:

ALOBAIDI, B.;
HASHIMI, S. M.;
ALQOSAIBI, A. I.;
ALQURASHI, N.;
ALHAZMI, S.

Publication type:

Article

Curcumin protects against testis-specific side effects of irinotecan.

Published in:

European Review for Medical & Pharmacological Sciences, 2021, v. 25, n. 23, p. 7440

By:

UYANIK, Ö.;
GÜRBÜZ, Ş.;
CIFTCI, O.;
OĞUZTÜRK, H.;
AYDIN, M.;
CETIN, A.;
BAŞAK, N.;
TURTAY, M. GÖKHAN;
YÜCEL, N.

Publication type:

Article

MiR-181d inhibits cell proliferation and metastasis through PI3K/AKT pathway in gastric cancer.

Published in:

European Review for Medical & Pharmacological Sciences, 2019, v. 23, n. 20, p. 8861

By:

JIANG, K.;
XIE, L. F.;
XIAO, T. Z.;
QIU, M. Y.;
WANG, W. L.

Publication type:

Article

Using 5-fluorouracil-encored plga nanoparticles for the treatment of colorectal cancer: the in-vitro characterization and cytotoxicity studies.

Published in:

Nanomedicine Journal, 2020, v. 7, n. 3, p. 211, doi. 10.22038/nmj.2020.07.0005

By:

Pandey, Aditya Nath;
Rajpoot, Kuldeep;
Jain, Sunil K.

Publication type:

Article

The effects Metformin/Irinotecan-loaded PLGA nanoparticles on glutamate re-uptake time and alteration EAAT1 gene expression level in vitro.

Published in:

Nanomedicine Journal, 2019, v. 6, n. 1, p. 35, doi. 10.22038/nmj.2019.06.005

By:

Taghizadehghalehjoughi, Ali;
Hacimuftuoglu, Ahmet;
Cetin, Meltem;
Kaplan, Afife Busra Ugur;
Butuner, Selcuk;
Taspinar, Numan;
Mohammadzadeh, Maryam

Publication type:

Article

Encapsulation of irinotecan in polymeric nanoparticles: Characterization, release kinetic and cytotoxicity evaluation.

Published in:

Nanomedicine Journal, 2016, v. 3, n. 3, p. 159, doi. 10.7508/nmj.2016.03.003

By:

Mohammady, Heydar;
Dinarvand, Rassoul;
Manesh, Mehdi Esfandyari;
Ebrahimnejad, Pedram

Publication type:

Article

Comparative physiological and biochemical evaluation of salt and nickel tolerance mechanisms in two contrasting tomato genotypes.

Published in:

Physiologia Plantarum, 2020, v. 168, n. 1, p. 27, doi. 10.1111/ppl.12930

By:

Amjad, Muhammad;
Ameen, Nuzhat;
Murtaza, Behzad;
Imran, Muhammad;
Shahid, Muhammad;
Abbas, Ghulam;
Naeem, Muhammad A.;
Jacobsen, Sven‐Erik

Publication type:

Article

In Silico Study of Camptothecin-Based Pro-Drugs Binding to Human Carboxylesterase 2.

Published in:

Biomolecules (2218-273X), 2024, v. 14, n. 2, p. 153, doi. 10.3390/biom14020153

By:

Beierlein, Frank;
Horn, Anselm H. C.;
Sticht, Heinrich;
Mokhir, Andriy;
Imhof, Petra

Publication type:

Article

Novel Set of Diarylmethanes to Target Colorectal Cancer: Synthesis, In Vitro and In Silico Studies.

Published in:

Biomolecules (2218-273X), 2023, v. 13, n. 1, p. 54, doi. 10.3390/biom13010054

By:

Hadj Mohamed, Ameni;
Pinon, Aline;
Lagarde, Nathalie;
Goya Jorge, Elizabeth;
Mouhsine, Hadley;
Msaddek, Moncef;
Liagre, Bertrand;
Sylla-Iyarreta Veitía, Maité

Publication type:

Article

Proinflammatory and Cancer-Promoting Pathobiont Fusobacterium nucleatum Directly Targets Colorectal Cancer Stem Cells.

Published in:

Biomolecules (2218-273X), 2022, v. 12, n. 9, p. 1256, doi. 10.3390/biom12091256

By:

Cavallucci, Virve;
Palucci, Ivana;
Fidaleo, Marco;
Mercuri, Antonella;
Masi, Letizia;
Emoli, Valeria;
Bianchetti, Giada;
Fiori, Micol Eleonora;
Bachrach, Gilad;
Scaldaferri, Franco;
Maulucci, Giuseppe;
Delogu, Giovanni;
Pani, Giovambattista

Publication type:

Article

Target-Based Small Molecule Drug Discovery for Colorectal Cancer: A Review of Molecular Pathways and In Silico Studies.

Published in:

Biomolecules (2218-273X), 2022, v. 12, n. 7, p. N.PAG, doi. 10.3390/biom12070878

By:

Moshawih, Said;
Lim, Ai Fern;
Ardianto, Chrismawan;
Goh, Khang Wen;
Kifli, Nurolaini;
Goh, Hui Poh;
Jarrar, Qais;
Ming, Long Chiau

Publication type:

Article

FL118, acting as a 'molecular glue degrader', binds to dephosphorylates and degrades the oncoprotein DDX5 (p68) to control c‐Myc, survivin and mutant Kras against colorectal and pancreatic cancer with high efficacy.

Published in:

Clinical & Translational Medicine, 2022, v. 12, n. 5, p. 1, doi. 10.1002/ctm2.881

By:

Ling, Xiang;
Wu, Wenjie;
Aljahdali, Ieman A. M.;
Liao, Jianqun;
Santha, Sreevidya;
Fountzilas, Christos;
Boland, Patrick M.;
Li, Fengzhi

Publication type:

Article

Kindlin‐1 modulates the EGFR pathway and predicts sensitivity to EGFR inhibitors across cancer types.

Published in:

Clinical & Translational Medicine, 2022, v. 12, n. 4, p. 1, doi. 10.1002/ctm2.813

By:

Azorin, Paula;
Bonin, Florian;
Tariq, Zakia;
Petitalot, Ambre;
Coussy, Florence;
Marangoni, Elisabetta;
Becette, Veronique;
Denoux, Yves;
Vincent‐Salomon, Anne;
Le Tourneau, Christophe;
Larbi Cherif, Linda;
Klijanienko, Jerzy;
Kamal, Maud;
Bièche, Ivan;
Lidereau, Rosette;
Driouch, Keltouma

Publication type:

Article

C20orf24 promotes colorectal cancer progression by recruiting Rin1 to activate Rab5‐mediated mitogen‑activated protein kinase/extracellular signal‐regulated kinase signalling.

Published in:

Clinical & Translational Medicine, 2022, v. 12, n. 4, p. 1, doi. 10.1002/ctm2.796

By:

Wang, Yang;
Zhang, Jing;
Zheng, Can‐Can;
Huang, Zi‐Jia;
Zhang, Wei‐Xia;
Long, Yun‐Lin;
Gao, Gui‐Bin;
Sun, Yue;
Xu, Wen Wen;
Li, Bin;
He, Qing‐Yu

Publication type:

Article

FTO promotes colorectal cancer progression and chemotherapy resistance via demethylating G6PD/PARP1.

Published in:

Clinical & Translational Medicine, 2022, v. 12, n. 3, p. 1, doi. 10.1002/ctm2.772

By:

Wang, Jiyan;
Qiao, Yaya;
Sun, Mingming;
Sun, Huanran;
Xie, Fei;
Chang, Hongkai;
Wang, Yingzhi;
Song, Jiaqi;
Lai, Sizhen;
Yang, Chenxin;
Li, Xichuan;
Liu, Shuangping;
Zhao, Xuanzhu;
Ni, Kemin;
Meng, Kewei;
Zhang, Shuai;
Shan, Changliang;
Zhang, Chunze

Publication type:

Article

Baicalein is a novel TLR4‐targeting therapeutics agent that inhibits TLR4/HIF‐1α/VEGF signaling pathway in colorectal cancer.

Published in:

Clinical & Translational Medicine, 2021, v. 11, n. 11, p. 1, doi. 10.1002/ctm2.564

By:

Chen, Minting;
Zhong, Keying;
Tan, Jincheng;
Meng, Mingjing;
Liu, Chok Mei;
Chen, Baisen;
Huang, Chunhua;
Wong, Hoi Leong Xavier;
Bian, Zhaoxiang;
Su, Tao;
Kwan, Hiu Yee

Publication type:

Article

Prevotella contributes to individual response of FOLFOX in colon cancer.

Published in:

Clinical & Translational Medicine, 2021, v. 11, n. 9, p. 1, doi. 10.1002/ctm2.512

By:

Hou, Xiao‐Ying;
Zhang, Pei;
Du, Hong‐Zhi;
Gao, Yi‐Qiao;
Sun, Rui‐Qi;
Qin, Si‐Yuan;
Tian, Yuan;
Li, Jing;
Zhang, Yu‐Xin;
Chu, Wei‐Hua;
Zhang, Zun‐Jian;
Xu, Feng‐Guo

Publication type:

Article

Transfer of metastatic traits via miR‐200c in extracellular vesicles derived from colorectal cancer stem cells is inhibited by atractylenolide I.

Published in:

Clinical & Translational Medicine, 2020, v. 10, n. 4, p. 1, doi. 10.1002/ctm2.139

By:

Tang, Dongxin;
Xu, Xiaofen;
Ying, Jialiang;
Xie, Tian;
Cao, Gang

Publication type:

Article

Passage of irinotecan and its active metabolite, SN-38, into human milk.

Published in:

Journal of Clinical Pharmacy & Therapeutics, 2016, v. 41, n. 5, p. 579, doi. 10.1111/jcpt.12428

By:

Nakagawa, J.;
Terui, K.;
Hosoi, K.;
Ueno, K.;
Yokoyama, Y.;
Hayakari, M.

Publication type:

Article

Evaluation of second-line apatinib plus irinotecan as a treatment for advanced gastric adenocarcinoma or gastroesophageal conjunction adenocarcinoma: a prospective, multicenter phase II trial.

Published in:

Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1072943

By:

Jinglei Qu;
Xin He;
Ying Luo;
Ping Yu;
Ying Chen;
Jing Liu;
Xin Wang;
Chang Wang;
Tingting Liang;
Yuxian Bai;
Yu Han;
Li Man;
Chuanchun Leng;
Caiyun Zhou;
Lijie He;
Yunpeng Liu;
Xiujuan Qu

Publication type:

Article

Effectiveness and safety of capecitabine, irinotecan and panitumumab in advanced colorectal cancer .

Published in:

Frontiers in Oncology, 2023, v. 13, p. 1, doi. 10.3389/fonc.2023.1138357

By:

Pui Lam Yip;
Wai Him Brian Fung;
Francis Ann Shing Lee;
Chak Fei Lee;
Natalie Sean Man Wong;
Shing Fung Lee

Publication type:

Article

Dinutuximab beta combined with chemotherapy in patients with relapsed or refractory neuroblastoma.

Published in:

Frontiers in Oncology, 2023, v. 13, p. 1, doi. 10.3389/fonc.2023.1082771

By:

Wieczorek, Aleksandra;
Zaniewska-Tekieli, Anna;
Ehlert, Karoline;
Pawinska-Wasikowska, Katarzyna;
Balwierz, Walentyna;
Lode, Holger

Publication type:

Article

Multicenter, single-arm, phase II study (CAP) of radiotherapy plus liposomal irinotecan followed by camrelizumab and anti-angiogenic treatment in advanced solid tumors.

Published in:

Frontiers in Immunology, 2023, v. 14, p. 1, doi. 10.3389/fimmu.2023.1133689

By:

Jie Shen;
Jing Yan;
Juan Du;
Xiaoqin Li;
Jia Wei;
Qin Liu;
Hongmei Yong;
Xiaolu Wang;
Xiaofeng Chang;
Zhou Ding;
Wu Sun;
Chenxi Liu;
Sihui Zhu;
Jingyi Guo;
Huajun Li;
Ying Liu;
Wulou Zhang;
Zonghang Liu;
Rutian Li;
Baorui Liu

Publication type:

Article

Natural killer cell therapy potentially enhances the antitumor effects of bevacizumab plus irinotecan in a glioblastoma mouse model.

Published in:

Frontiers in Immunology, 2023, v. 13, p. 01, doi. 10.3389/fimmu.2022.1009484

By:

Thi-Anh-Thuy Tran;
Young-Hee Kim;
Thi-Hoang-Oanh Duong;
JayaLakshmi Thangaraj;
Tan-Huy Chu;
Shin Jung;
In-Young Kim;
Kyung-Sub Moon;
Young-Jin Kim;
Tae-Kyu Lee;
Chul Won Lee;
Hyosuk Yun;
Je-Jung Lee;
Hyun-Ju Lee;
Kyung-Hwa Lee;
Tae-Young Jung

Publication type:

Article

DNA Methylation Biomarkers Predict Objective Responses to PD-1/PD-L1 Inhibition Blockade.

Published in:

Frontiers in Genetics, 2019, p. 1, doi. 10.3389/fgene.2019.00724

By:

Xue, Gang;
Cui, Ze-Jia;
Zhou, Xiong-Hui;
Zhu, Yue-Xing;
Chen, Ying;
Liang, Feng-Ji;
Tang, Da-Nian;
Huang, Bing-Yang;
Zhang, Hong-Yu;
Hu, Zhi-Huang;
Yuan, Xi-Yu;
Xiong, Jianghui

Publication type:

Article

Germline Testing, Molecular Profiling Now Recommended in NCCN Pancreatic Cancer Guideline.

Published in:

Journal of Oncology Navigation & Survivorship, 2019, v. 10, n. 5, p. 195

By:

Tempero, Margaret A.

Publication type:

Article